← Eichor
Condition: Squamous Cell Cancer Of Head And Neck Scchn Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Squamous Cell Cancer Of Head And Neck Scchn

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Clinical Trial Comparing Induction Treatment With EGFR-ADC MRG003 Alone or in Combination With the Anti PD1 Pucotenlimab
Phase 2 · 1 location(s) · Groupe Oncologie Radiotherapie Tete et Cou · NCT06959108Penpulimab in Combination With Cetuximab as First-line Treatment in R/M SCCHN
Phase 2 · 2 location(s) · Eye & ENT Hospital of Fudan University · NCT05260671Neoadjuvant Pembrolizumab and IO102-103 for Squamous Cell Carcinoma of the Head and Neck (SCCHN).
Phase 2 · 5 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT05977907A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Phase 1 · 30 location(s) · Pfizer · NCT07090499Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer
Phase 1 · 1 location(s) · VLP Therapeutics · NCT06736379Comparing Postoperative Adjuvant Cisplatin Concurrent Chemoradiotherapy With Adjuvant Radiotherapy Alone for Intermediat
Phase 3 · 7 location(s) · Sun Yat-sen University · NCT07125755Study Comparing Ivonescimab Alone or Ivonescimab in Combination With Ligufalimab Versus Pembrolizumab for the Treatment
Phase 3 · 1 location(s) · Groupe Oncologie Radiotherapie Tete et Cou · NCT07264075Study of Cetuximab Plus/Minus Weekly Paclitaxel After Progression To First-Line Pembrolizumab Plus Platinum-5FU in Subje
Phase 2 · 17 location(s) · Grupo Español de Tratamiento de Tumores de Cabeza y Cuello · NCT06856213Intratumoral N17350 in Advanced Solid Tumors
Phase 1/Phase 2 · 8 location(s) · Onchilles Pharma Inc · NCT07339176A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
Phase 1/Phase 2 · 47 location(s) · Bristol-Myers Squibb · NCT04895709Stereotactic MRI-guided Focused Ultrasound Mesencephalotomy
NA · 6 location(s) · University of Virginia · NCT07405645A Beta-only IL-2 ImmunoTherapY Study
Phase 1/Phase 2 · 27 location(s) · Medicenna Therapeutics, Inc. · NCT05086692Safety and Feasibility of Nivolumab-IRDye800CW in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)
Phase 1 · 1 location(s) · Vanderbilt-Ingram Cancer Center · NCT07460765SMP-3124LP in Adults With Advanced Solid Tumors
Phase 1/Phase 2 · 10 location(s) · Sumitomo Pharma America, Inc. · NCT06526819Head and Neck Carcinoma Clinical Research Platform for Molecular and Blood-based Biomarkers, Treatment and Outcome
Phase N/A · 2 location(s) · AIO-Studien-gGmbH · NCT06380686Phase II Study of Daily Adaptive Radiotherapy for Submandibular Gland-sparing in Head and Neck Cancer
NA · 1 location(s) · University Health Network, Toronto · NCT07348887EMITT-1 (ERAP Mediated Immunopeptidome Targeting Trial - 1)
Phase 1/Phase 2 · 29 location(s) · Grey Wolf Therapeutics · NCT06923761Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head
Phase 2 · 676 location(s) · ECOG-ACRIN Cancer Research Group · NCT02734537
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.